As part of the IP Osgoode Speaks Series, Dr. Siva Thambisetty, an associate professor of law at the London School of Economics, visited Osgoode Hall Law School to speak on…
Category: Patent Practice
Utility Emphasis Lacking in the Examination of Aggregations
The distinction between combinations and aggregations is a well-accepted principle of patent law. A combination is an assemblage of known elements whose combined use leads to a result that is…
The View Ahead for Software Patent Applications: USPTO Releases Update to Guidance on Patent Subject Matter Eligibility
This article is cross-posted with permission from Bereskin & Parr. The United States Patent and Trademarks Office (USPTO) has released an updated set of Eligibility Examination Guidelines to provide guidance…
Patent Strategies in Your First Few Years of a New Business
Introduction A new business that plans to bring a new and innovative product or service to market ought to address patents right from the first draft of their business plan.…
An Unexpected Infringement: There and Back Again
On March 16, 2015, Justice Barnes held that AstraZeneca’s Patent No 1,292,693 (“’693 Patent”), a formulation patent for omeprazole, was valid and infringed by Apotex (2015 FC 322). This decision…
China’s Bitter Medicine for Gilead: SIPO Cancels Viread Patent
Last August, China’s State Intellectual Property Office (SIPO) invalidated the core patent for Gilead Sciences‘ flagship drug Viread (as was reported by IPR Daily and a number of other news sources). This…